Dr. Peter Kash is a co-founder and Vice-Chairman of TargImmune Therapeutics (Switzerland). He was formerly a co-founder and partner and Chairman of Two River Group and President of Riverbank Capital Securities specializing in creating and financing several biotech companies including Kite Pharma, Edgemont Pharmaceuticals, and Intercept Pharmaceuticals. He has cofounded more than a dozen biotech companies and raised in excessive of $2 billion in private/public financing, creating more than $20 billion in peak aggregate market value. Dr. Kash has worked on Wall Street for 30 years including at Shearson Lehman Hutton and Paramount Capital. At Paramount he co-founded and financed PolaRx Biopharmaceuticals; developing the first cancer drug from China, Trisenox approved by the FDA. The portfolio companies have received a total of 6 FDA approvals to date.
From 1990-1992 he was an Associate Professor of Marketing at Polytechnic University. During 1996-2000 he was an Adjunct Professor of Entrepreneurship at the Wharton Business School. During 2000-2002 he was a Visiting Professor of Entrepreneurship at the Graduate School of Business at Nihon University in Tokyo and in 2015 a Visiting Professor at Hebrew University. He has frequently lectured and served as a Keynote Speaker worldwide in many of the 70 countries he has visited.
His education includes a B.S. in Management Science from S.U.N.Y. Binghamton and an MBA in International Banking and Finance from the Lubin School of Business at Pace University. He holds a Doctorate in Education at The Azrieli Graduate School of Yeshiva University. Dr. Kash completed post graduate classes on Making Boards of Directors More Effective at Harvard Business School.
He has authored several books including the international best seller Make Your Own Luck, (Prentice Hall), now in 8 languages distributed in more than 70 countries and (international bestseller Freedom From Disease (St. Martin’s Press). His third book Take Two Tablets Medicine from the Bible. You might have seen Peter as a television host for FNN’s and as a guest on CNBC, Fox and Friends, Show, WB11, or with Dr. Oz Radio Show, and more recently at his first Tedx lecture in London 2019.
